In Brief
This article was originally published in The Tan Sheet
Executive Summary
ProPhase rebuffs revised Matrixx bid; “meth-deterring” Nexafed arrives in December; suits against Bayer, J&J and Pfizer dispute OTC expiration dates; Cantarell expands Nestle role; more news In Brief.